FLC
CLMT icon

Fifth Lane Capital’s Calumet Specialty Products CLMT Stock Holding History

Fifth Lane Capital’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,500
Closed -$186K – 123
2024
Q1 		$186K Buy
+12,500
New +$199K 0.16% 79

Other funds holding CLMT

WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Fifth Lane Capital's CLMT Position: Q1 2025 in Review

Fifth Lane Capital sold out of Calumet Specialty Products (CLMT) in Q1 2025, closing a stake of 14,000 shares — an estimated $308K sold.

Fifth Lane Capital first reported a position in CLMT in Q1 2024 and held it in 4 quarters. The position peaked at $308K in Q4 2024. 129 funds tracked by Wall St. Rank hold CLMT as of Q1 2025.

  • Fifth Lane Capital reported no remaining Calumet Specialty Products position as of Q1 2025 after selling out during the quarter.
  • Fifth Lane Capital sold 14,000 Calumet Specialty Products shares in Q1 2025, an estimated $308K.
  • Fifth Lane Capital first reported a position in Calumet Specialty Products in Q1 2024 and held it in 4 quarters.
  • Fifth Lane Capital's Calumet Specialty Products position peaked at $308K in Q4 2024.
  • 129 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2025.

Based on Fifth Lane Capital's 13F filing for Q1 2025, filed 13 May 2025.